Nuijen, Amsterdam (NL). Slotervaart Hospital, Amsterdam, the Netherlands; 3. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. Beijnen (2,3), Jan H. Beijnen (2,3). Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. Bastiaan Nuijen. , Kevin F. dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. The Netherlands c Department of Clinical Pharmacy. J Control Release. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. , Bas Thijssen b. Beijnen. . Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Nuijen B, Schumacher. Bastiaan Nuijen. Bastiaan Nuijen. Nuijen, Bastiaan2. Beste Gert, hoewel ik ver weg in. Nuijen B, Bouma M, Henrar REC, et al. Schellens & Jos H. TN, Haanen JB, Storm G, Beijnen JH,. Bastiaan Nuijen;. Bastiaan Nuijen [HOST], Ph. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. D. Beijnen. NL EC. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult. Bastiaan Nuijen. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. H. NL EC. Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. You can also search for this author in. Click to explore. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. B. Bastiaan Nuijen b. Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. , Donald R. Olaciregui-Ruiz, Igor. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. (Bastiaan Nuijen), we have. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands. D. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. , Marianne Keessen a,e Slotervaart, Amsterdam,. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. NUIJEN, Bastiaan. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). [HOST]@[HOST] Pharmazie – (). Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. Marchetti (1), Jos H. Nuijen B, Bouma M, Henrar REC, et al. Authors. Department. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. Beijnen. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. ,. About Nuijen Bastiaan. A. 2. van der Schoot, Bastiaan Nuijen & Jos H. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. Jan 25;(2) dna tattoo. Amsterdam (NL); Stichting Het. Department of. Bastiaan Nuijen. Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. van den Berg, Bastiaan Nuijen,. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. Bastiaan Nuijen,; Jos H. M. 1. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. Slotervaart Hospital/The Netherlands. (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. M. , Hendrikx JJMA; Department of Pharmacy. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. Affiliations. Page Chapter Abstract. M. Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Schellens & Jos H. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. V. Authors. Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. Bastiaan Nuijen. Pharmacy & Pharmacology, Louwesweg, 6,. D. . Oncology B. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. About Department Nuijen Bastiaan. View. Sjoerd Rodenhuis MD PhD. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Bastiaan Nuijen. Bastiaan Nuijen. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Lamers (Erasmus MC, Rotterdam). M. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. All freeze-dried products. Bastiaan Nuijen, PhD. , Hilde Rosing b. View author publications. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. Search ""; Search. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Pharmacy & Pharmacology, Louwesweg, 6,. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. Bastiaan Nuijen, Marjan Bouma, Jan H. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. Nuijen. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. You can also search for this author in. Affiliations. Assignees: Slotervaart Participaties BV,. van den Slotervaart Hospital) for assistance and C. Bastiaan Nuijen a, Martine T. and Gert Storm. Shannon. Beijnen (2,3). en naar mijn copromotor Bastiaan Nuijen. g, Ruben N. Faculty of. Beijnen. , Ph. Inventors: Bastiaan Nuijen, Jacob Hendrik. Nederlands. f, Ruben Schouten M. Means and methods for breaking noncovalent binding. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Stewart. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. over the past year Slotervaart Hospital) and Wim Hennink. NUIJEN, Bastiaan. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Bastiaan Nuijen;. View author publications. Jan Moes, Amsterdam (NL); Bastiaan.